“FINAL HEIGHT AND ENDOCRINE COMPLICATIONS IN PATIENTS WITH ?-THALASSSEMIA INTERMEDIA: OUR EXPERIENCE IN NON-TRANSFUSED VERSUS INFREQUENTLY TRANSFUSED PATIENTS AND CORRELATIONS WITH LIVER IRON CONTENT: None”, Mediterr J Hematol Infect Dis, vol. 11, no. 1, p. e2019026, Apr. 2019, doi: 10.4084/mjhid.2019.026.